4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-017764
EVP, North America Commercial sold 15,548 shares at an average $10.85 ($168,631)
- EVP, North America Commercial acquired 1,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Grady Brendan P. · EVP, North America Commercial
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-02 | Sale : show line 1 in the form | −15,085 | $10.85 | $163,601 | 14,868.49 | D |
| 2021-03-03 | Exercise or conversion : show line 2 in the form | +1,166 | 16,034.49 | D | ||
| 2021-03-03 | Sale : show line 3 in the form | −463 | $10.86 | $5,029 | 15,571.49 | D |
| Open-market sales · 15,548 sh · avg $10.85 · $168,631 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-03 | Exercise or conversion : show line 4 in the form Restricted Share Units | −1,166 | 0 | D |
Loading xslF345X03/doc4.xml…